Why the study?
Does IGF-1 improve neovascularization and increase IL-8 in rats with isoproterenol-induced myocardial infarction?
Does IGF-1 improve neovascularization and increase IL-8 in rats with isoproterenol-induced myocardial infarction?
IGF-1 protects the ischemic myocardium in a rat model of myocardial infarction by increasing IL-8 production and stimulating neovascularization.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for IGF-1 in rat myocardial infarction; leaves open translation to human ischemic disease.
Angiogenesis factors are produced in response to hypoxic or ischemic insult at the site of pathology, which will cause neovascularization. Insulin like growth factor-1 (IGF-1) exerts potent proliferative, angiogenic and anti-apoptotic effects in target tissues. The present study was aimed to evaluate the effects of IGF-1 on circulating level of angiogenic cytokine interleukin-8 (IL-8), in experimentally-induced myocardial ischemia in rats. Male Sprague-Dawley rats were divided into control, IGF-1 treated (2 μg/kg/day subcutaneously, for 5 and 10 days), isoproterenol (ISO) treated (85 mg/kg, subcutaneously for two days) and ISO with IGF-1 treated (for 5 and 10 days). Heart weight, serum IGF-1, IL-8 and cardiac marker enzymes (CK-MB and LDH) were recorded after 5 and 10 days of treatment. Histopathological analyses of the myocardium were also done. There was a significant increase in serum cardiac markers with ISO treatment indicating myocardial infarction in rats. IGF-1 level increased significantly in ISO treated groups and the level of IGF-1 was significantly higher after 10 days of treatment. IL-8 level increased significantly after ISO treatment after 5 and 10 days and IGF-1 concurrent treatment to ISO rats had significantly increased IL-8 levels. Histopathologically, myocyte necrosis and nuclear pyknosis were reduced significantly in IGF-1 treated group and there were numerous areas of capillary sprouting suggestive of neovascularization in the myocardium. Thus, IGF-1 protects the ischemic myocardium with increased production of circulating angiogenic cytokine, IL-8 and increased angiogenesis.
No takes yet. Share an insight, caveat, or question.
Haleagrahara et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: